Cetera Investment Advisers
IDNA icon

Cetera Investment Advisers’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Cetera Investment Advisers’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$528K Buy
15,642
+321
+2% +$9.63K ﹤0.01% 3649
2026
Q1 		$445K Buy
15,321
+878
+6% +$25.5K ﹤0.01% 3619
2025
Q4 		$378K Buy
14,443
+2,892
+25% +$74.4K ﹤0.01% 3681
2025
Q3 		$273K Buy
11,551
+136
+1% +$3.01K ﹤0.01% 3910
2025
Q2 		$234K Buy
11,415
+554
+5% +$11.2K ﹤0.01% 3604
2025
Q1 		$223K Sell
10,861
-500
-4% -$11.2K ﹤0.01% 3522
2024
Q4 		$257K Sell
11,361
-114
-1% -$2.74K ﹤0.01% 3229
2024
Q3 		$282K Sell
11,475
-759
-6% -$18.5K ﹤0.01% 3118
2024
Q2 		$283K Sell
12,234
-1,100
-8% -$25.8K ﹤0.01% 3081
2024
Q1 		$321K Buy
+13,334
New +$313K ﹤0.01% 2971
2021
Q2 		– Sell
-5,412
Closed -$247K – 1795
2021
Q1 		$247K Sell
5,412
-285
-5% -$13.9K ﹤0.01% 1350
2020
Q4 		$262K Buy
+5,697
New +$246K 0.01% 1312

Other funds holding IDNA

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $1.05B AUM 18.22% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
TF
Trek Financial Scottsdale, Arizona $2.01B AUM 53.49% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cetera Investment Advisers's IDNA Position: Q2 2026 in Review

Cetera Investment Advisers increased its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 2.1% in Q2 2026, buying an estimated $9.63K and bringing the position to 15,642 shares worth $528K. The position accounts for ﹤0.01% of the portfolio, ranked #3649.

Cetera Investment Advisers first reported a position in IDNA in Q4 2020 and has held it in 12 quarters since. 66 funds tracked by Wall St. Rank hold IDNA as of Q2 2026.

  • Cetera Investment Advisers held 15,642 shares of iShares Genomics Immunology and Healthcare ETF worth $528K as of Q2 2026.
  • Cetera Investment Advisers bought 321 iShares Genomics Immunology and Healthcare ETF shares in Q2 2026, an estimated $9.63K.
  • iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #3649 holding.
  • Cetera Investment Advisers first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2020 and has held it in 12 quarters since.
  • 66 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.